![](https://tracker.live.rns-distribution.com/track.live-rns/4609733_75d1671758db0ed18eba2dbba83793b2.png)
The information communicated within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 which is part of UK law by virtue of the European Union (withdrawal) Act 2018. Upon the publication of this announcement, this inside information is now considered to be in the public domain.
12 December 2022
Clean Power Hydrogen Plc
("CPH2", the "Company" or the "Group")
Investment in ATOME Energy plc to accelerate roll out of MFE220 and MFE440 electrolysers across South America
CPH2, the UK-based green hydrogen technology and manufacturing company that has developed the IP-protected Membrane-Free Electrolyser ("MFE"), is pleased to announce that the Company has subscribed for 1,412,429 new Ordinary Shares in ATOME Energy plc ("ATOME") at a price of 106.2 pence per share for a total investment of £1.5m as part of ATOME's placing announced today. The subscription will be settled out of the Company's existing cash resources.
In March 2022, CPH2 and ATOME entered into a purchase order for the sale of a 1MW MFE220 electrolyser to be deployed in ATOME's Paraguay mobility project. The two companies also entered into a non-binding collaboration agreement in respect of potential future orders of electrolyser units for ATOME's international hydrogen and ammonia projects, and to investigate and discuss a potential joint venture for the future production of electrolysers in-country to serve the Latin American market using CPH2's technology and know-how.
Today's investment in ATOME accelerates both ATOME's and CPH2's roll out of green hydrogen electrolysers across South America and is a demonstration of CPH2's commitment to ATOME's Mobility Division, which is expected to be the first commercial production of hydrogen for transport in Paraguay when it commences next year.
ATOME, a fellow Yorkshire headquartered company, which listed on the AIM market of the London Stock Exchange in 2021, is an international company focused on green hydrogen and ammonia production with advanced plans for up to 500MW of projects located in Paraguay and Iceland with a signed Power Purchase Agreement with ANDE, the Paraguayan National Power Company, for a 120MW dedicated green ammonia facility. In the 12 months to 31 December 2021, ATOME recorded a loss for the period of US$2.2 million.
Jon Duffy, Chief Executive Officer of CPH2, commented:
"Today's announcement marks an extension of our ongoing collaboration with ATOME for the use of CPH2's electrolyser units in ATOME's international hydrogen and ammonia projects. The Company's investment in ATOME is expected to accelerate ATOME's plans for the commercial production of hydrogen in Paraguay employing CPH2's MFE220 electrolyser and therefore accelerate the roll out of our electrolysers across South America."
For more information, please contact:
Clean Power Hydrogen Plc | via Camarco |
Jon Duffy, Chief Executive Officer | |
| |
Cenkos Securities plc - NOMAD & Broker | |
Neil McDonald | +44 (0)131 220 9771 |
Peter Lynch | +44 (0)131 220 9772 |
Adam Rae | +44 (0)131 220 9778 |
| |
Camarco PR | + 44(0) 20 3 757 4980 |
Billy Clegg | |
Owen Roberts | |
Fergus Young | |
To find out more, please visit: https://www.cph2.com
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean Power") which has almost a decade of dedicated research and product development experience. This experience has resulted in the creation of simple, safe and sustainable technology which is designed to deliver a modular solution to the hydrogen production market in a cost-effective, scalable, reliable and long-lasting manner. The Group's strategic objective is to deliver the lowest LCOH in the market in relation to the production of green hydrogen. The Group's MFE technology is already commercially available and demonstrating cost efficiencies and technological advantages. CPH2 is listed on the AIM market and trades under the ticker LON:CPH2.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.